arrow
A

A. Cicchetti

Fondazione IRCCS Istituto Nazionale dei Tumori
H指数:15
被引数:654

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Microvascular health status as a novel predictor of acute side effects after radiotherapy: a quantitative analysis across three cancer sites

微血管健康状态作为放射治疗后急性不良反应的新型预测因子:一项跨越三个癌症部位的定量分析

2026-07-110
PRE
Integrating biomarker-derived individual treatment response assessment into Bayesian trial design for personalized cancer treatment

将基于生物标志物的个体治疗反应评估整合到贝叶斯试验设计中,以实现个性化癌症治疗

2026-03-120
OAAI
Predictors of acute lymphopenia after radiotherapy for prostate cancer including pelvic node irradiation: results of a real-world prospective multi-centric study

前列腺癌盆腔淋巴结放疗后急性淋巴细胞减少的预测因素:一项真实世界多中心前瞻性研究的结果

2026-01-010
OA
INCORPORATING INDIVIDUAL EARLY RESPONSE IN THE DOSE-EFFECT RELATIONSHIP OF COMPLETE PATHOLOGICAL RESPONSE FOLLOWING NEO-ADJUVANT RADIO-CHEMOTHERAPY FOR RECTAL CANCER

将个体早期反应纳入新辅助放化疗后直肠癌完全病理反应的剂量-效应关系中

2025-12-050
PRE
Training and temporally validating an NTCP model of acute toxicity after whole breast radiotherapy, including the impact of advanced delivery techniques
2025-03-010
PRE
Multi-institutional Knowledge-Based (KB) plan prediction benchmark models for whole breast irradiation
2025-02-010
PRE
Intestinal microbiota composition is predictive of radiotherapy-induced acute gastrointestinal toxicity in prostate cancer patients
2024-08-010
OAAI
Pelvic bone marrow dose-volume predictors of late lymphopenia following pelvic lymph node radiation therapy for prostate cancer
2024-06-012
PRE
High weekly integral dose and larger fraction size increase risk of fatigue and worsening of functional outcomes following radiotherapy for localized prostate cancer
2022-10-262
OAAI
Treatment time and circadian genotype interact to influence radiotherapy side-effects. A prospective European validation study using the REQUITE cohort
2022-10-018
OAAI
Knowledge-based multi-institution plan prediction of whole breast irradiation with tangential fields
2022-10-0113
PRE
Health-related quality of life 24 months after prostate cancer diagnosis: an update from the Pros-IT CNR prospective observational study
2022-03-016
PRE
A Deep Learning Approach Validates Genetic Risk Factors for Late Toxicity After Prostate Cancer Radiotherapy in a REQUITE Multi-National Cohort
2020-10-1524
OAAI